PTCT

PTC THERAPEUTICS, INC.

NasdaqGS · Healthcare

$89.55

-4.12% today

last filing 2026-07-06Pro sees filings in ~15 min

Price

hover · 4 moves explained

171 sells

Analyst consensus

Buy

$94.14target+5.1%vs $89.55 today

$65.00 low today target$124.00 high

14 analysts · ~12-month consensus · as of Jul 10. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 3 of last 4

Earnings per share · actual vs forecast

Q2 '25+21.9%

−$0.83

exp −$1.06

Q3 '25

$0.19

exp −$1.11

Q4 '25

−$1.80

exp −$0.41

Q1 '26+93.2%

−$0.03

exp −$0.44

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-07-08	Boulding Mark ElliottPlanned	EXEC. VP AND CLO	—Direct	745	$86.38	$64.4K
Sell	2026-07-08	Boulding Mark ElliottPlanned	EXEC. VP AND CLO	—Direct	645	$85.84	$55.4K
Sell	2026-07-08	Boulding Mark ElliottPlanned	EXEC. VP AND CLO	—Direct	1,036	$84.41	$87.4K
Sell	2026-07-08	Boulding Mark ElliottPlanned	EXEC. VP AND CLO	—Direct	387	$83.10	$32.2K
Exercise	2026-07-08	Boulding Mark ElliottPlanned	EXEC. VP AND CLO	—Direct	2,813	$46.54	$130.9K

Sell

Boulding Mark Elliott

EXEC. VP AND CLO · 2026-07-08

$64.4K

745 @ $86.38

Sell

Boulding Mark Elliott

EXEC. VP AND CLO · 2026-07-08

$55.4K

645 @ $85.84

Sell

Boulding Mark Elliott

EXEC. VP AND CLO · 2026-07-08

$87.4K

1,036 @ $84.41

Sell

Boulding Mark Elliott

EXEC. VP AND CLO · 2026-07-08

$32.2K

387 @ $83.10

Exercise

Boulding Mark Elliott

EXEC. VP AND CLO · 2026-07-08

$130.9K

2,813 @ $46.54

245 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →